U.S. publisher John Wiley & Sons Inc. has signed an agreement with the Mount Sinai School of Medicine to publish the Mount Sinai Journal of Medicine.
Wiley said it will re-launch the journal in January with a new design and editorial focus.
Published continuously since 1934 by The Mount Sinai Hospital in New York City, the Mount Sinai Journal of Medicine is issued six times a year and features clinical articles from all medical disciplines.
Wiley will re-launch the journal as the Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine. The publication will feature articles on the evolving nature of clinical care; its linkage with bio-medical research; and resulting opportunities for enhanced patient outcomes.
The new editorial focus will reflect the growing importance of translational and personalized medicine, Wiley said.
Copyright 2006 by United Press International
Related stories:
1918 flu antibodies resurrected from elderly survivors
Ninety years after the sweeping destruction of the 1918 flu pandemic, researchers at Monroe Carell Jr. Children's Hospital at Vanderbilt have recovered antibodies to the virus – from elderly survivors of the original outbreak.
Scientists uncover the key to controlling how stem cells develop
(PhysOrg.com) -- The results of a new study involving a McMaster University researcher provide insight into how scientists might control human embryonic stem cell differentiation.
Study indicates grape seed extract may reduce cognitive decline associated with Alzheimer's disease
A compound found in grape seed extract reduces plaque formation and resulting cognitive impairment in an animal model of Alzheimer's disease, new research shows. The study appears in the June 18 issue of
The Journal of Neuroscience.
Combining radiation and surgery significantly improves survival for head and neck cancer patients
Adding radiation therapy to surgery significantly improves overall survival in patients diagnosed with node-positive head and neck cancer when compared to treating with surgery alone, according to a study in the June issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
Enzyme for ubiquitin-dependent protein degradation linked to cellular senescence
A new study, published by Cell Press in the May 23rd issue of the journal
Molecular Cell, identifies a pivotal role for the CUL7 E3 ubiquitin ligase in growth control. The research makes an exciting new connection between the regulation of protein degradation and the initiation of cellular senescence.
Use of ghostwriters, guest authors appears frequent for studies involving rofecoxib
An examination of medical articles about rofecoxib (a nonsteroidal anti-inflammatory drug) and court documents from litigation related to this product indicates that company employees or other unacknowledged authors were frequently involved in writing clinical trial articles and review articles, but that primary authorship was often attributed to academically affiliated investigators who may have had little to do with the study, or who did not always disclose financial support from the sponsor of the study, according to an article in the April 16 issue of JAMA.
Scientists create first successful libraries of avian flu virus antibodies
An international group of American and Turkish research scientists, led by Sea Lane Biotechnologies, has created the first comprehensive monoclonal antibody libraries against avian influenza (H5N1) using samples from survivors of the 2005/2006 "bird flu" outbreak in Turkey.
Potential drug target identified for diabetes by studying novel gut-brain-liver circuit
Scientists at the Toronto General Hospital Research Institute have discovered a novel signaling pathway between three organs – the gut, the brain, and the liver – which lowers blood sugar when activated.